What is a potential adverse effect of Compound Sodium Lactate?

What is a potential adverse effect of Compound Sodium Lactate?

• A. Pulmonary oedema
• B. Acidosis
• C. Extreme hypertension
• D. Sepsis

Answer: (A)

Compound Sodium Lactate, commonly known as Hartmann’s solution, is a crystalloid intravenous fluid that contains sodium, chloride, lactate, and other components designed to replace lost fluids and electrolytes in patients. One potential adverse effect associated with the administration of this solution is pulmonary edema. This can occur if the fluid is administered too rapidly or in excessive amounts, leading to an overload of fluid in the circulation. The increase in intravascular volume can result in fluid leaking into the lung interstitium, manifesting as pulmonary edema, which can compromise respiratory function and gas exchange. In the context of the other options, while acidosis can occur with certain imbalances in electrolyte management, Compound Sodium Lactate is specifically formulated to help buffer acidity and provide lactate, which can be metabolized to bicarbonate, thus helping to mitigate acidosis rather than cause it. Extreme hypertension is not commonly linked with this fluid type; in fact, the effects on blood pressure are usually minimal unless significant volume overload occurs. Lastly, sepsis is a serious condition where infection leads to systemic inflammatory response, and while fluid therapy is crucial in the management of sepsis, Compound Sodium Lactate itself does not directly cause sepsis. Thus, the potential for pulmonary

Compound Sodium Lactate, commonly known as Hartmann’s solution, is a crystalloid intravenous fluid that contains sodium, chloride, lactate, and other components designed to replace lost fluids and electrolytes in patients.

One potential adverse effect associated with the administration of this solution is pulmonary edema. This can occur if the fluid is administered too rapidly or in excessive amounts, leading to an overload of fluid in the circulation. The increase in intravascular volume can result in fluid leaking into the lung interstitium, manifesting as pulmonary edema, which can compromise respiratory function and gas exchange.

In the context of the other options, while acidosis can occur with certain imbalances in electrolyte management, Compound Sodium Lactate is specifically formulated to help buffer acidity and provide lactate, which can be metabolized to bicarbonate, thus helping to mitigate acidosis rather than cause it. Extreme hypertension is not commonly linked with this fluid type; in fact, the effects on blood pressure are usually minimal unless significant volume overload occurs. Lastly, sepsis is a serious condition where infection leads to systemic inflammatory response, and while fluid therapy is crucial in the management of sepsis, Compound Sodium Lactate itself does not directly cause sepsis.

Thus, the potential for pulmonary